Cytotoxic properties of titanocenyl amides on breast cancer cell line MCF-7

Metal-Based Drugs

Volumn 2010, Issue , 2010, Pages

  Gao, Li Ming ^a   Meléndez, Enrique ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FUNCTIONAL GROUP; TITANOCENYL AMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CARCINOMA CELL; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL;

EID: 77952510063     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/286298     Document Type: Article

References (26)

1. Kpf H., Kpf-Maier P., Titanocene dichloride-the first metallocene with cancerostatic activity Angewandte Chemie International Edition 1979 18 6 477 478
2. Kpf-Maier P., Complexes of metals other than platinum as antitumour agents European Journal of Clinical Pharmacology 1994 47 1 1 16
3. Kpf-Maier P., Kpf H., Fricker S. P., Organometallic titanium, vanadium, niobium, molybdenum and rhenium complexes early transition metal antitumor drugs Metal Compounds in Cancer Therapy 1994 London, UK Chapman and Hall 109 146
4. Harding M. M., Mokdsi G., Antitumour metallocenes: structure-activity studies and interactions with biomolecules Current Medicinal Chemistry 2000 7 12 1289 1303
5. Melndez E., Titanium complexes in cancer treatment Critical Reviews in Oncology/Hematology 2002 42 3 309 315
6. Caruso F., Rossi M., Antitumor titanium compounds Mini-Reviews in Medicinal Chemistry 2004 4 1 49 60
7. Caruso F., Rossi M., Antitumor titanium compounds and related metallocenes Metal Ions in Biological Systems 2004 42 353 384
8. Kostova I., Titanium and vanadium complexes as anticancer agents Anti-Cancer Agents in Medicinal Chemistry 2009 9 8 827 842
9. Gao L. M., Matta J., Rheingold A. L., Melndez E., Synthesis, structure and biological activity of amide-functionalized titanocenyls: improving their cytotoxic properties Journal of Organometallic Chemistry 2009 694 26 4134 4139
10. Gansuer A., Franke D., Lauterbach T., Nieger M., A modular and efficient synthesis of functional Titanocenes Journal of the American Chemical Society 2005 127 33 11622 11623
11. Gansuer A., Winkler I., Worgull D., Modular synthesis of functional Titanocenes Organometallics 2008 27 5699
12. Mossman T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxycity assays Journal of Immunological Methods 1983 65 55
13. Denizot F., Lang R., Rapid colorimetric assay for cell growth and survivalmodifications to the tetrazolium dye procedure giving improved sensitivity and reliability Journal of Immunological Methods 1986 89 2 271 277
14. Si D., Wang X., Zhou Y.-H., Mechanism of CYP2C9 inhibition by flavones and flavonols Drug Metabolism and Disposition 2009 37 3 629 634
15. Gansuer A., Winkler I., Worgull D., Lauterbach T., FraWagner L., Prokop A., Carbonyl-substituted Titanocenes: a novel class of cytotoxic compounds with high antitumor and antileukemic activity ChemistryA European Journal 2008 14 4160
16. Allen O. R., Croll L., Gott A. L., Knox R. J., McGowan P. C., Functionalized cyclopentadienyl titanium organometallic compounds as new antitumor drugs Organometallics 2004 23 2 288 292
17. Weber H., Claffey J., Hogan M., Pampilln C., Tacke M., Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay Toxicology in Vitro 2008 22 2 531 534
18. Oberschmidt O., Hanauske A. R., Pampilln C., Sweeney N. J., Strohfeldt K., Tacke M., Antiproliferative activity of titanocene Y against tumor colony-forming units Anti-Cancer Drugs 2007 18 3 317 321
19. Pampilln C., Sweeney N. J., Strohfeldt K., Tacke M., Synthesis and cytotoxicity studies of new dimethylamino-functionalised and heteroaryl-substituted titanocene anti-cancer drugs Journal of Organometallic Chemistry 2007 692 11 2153 2159 (Pubitemid 46527633)
20. O'Connor K., Gill C., Tacke M., Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells Apoptosis 2006 11 7 1205 1214
21. Beckhove P., Oberschmidt O., Hanauske A. R., Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice Anti-Cancer Drugs 2007 18 3 311 315
22. Vessires A., Plamont M.-A., Cabestaing C., Proliferative and anti-proliferative effects of titanium-and iron-based metallocene anti-cancer drugs Journal of Organometallic Chemistry 2009 694 6 874 879
23. Claffey J., Gleeson B., Hogan M., Mller-Bunz H., Wallis D., Tacke M., Fluorinated derivatives of titanocene Y: synthesis and cytotoxicity studies European Journal of Inorganic Chemistry 2008 26 4074 4082
24. Eger S., Immel T. A., Claffey J., Titanocene difluorides with improved cytotoxic activity Inorganic Chemistry 2010 49 4 1292 1294
25. Ravera M., Gabano E., Baracco S., Osella D., Electrochemical evaluation of the interaction between antitumoral titanocene dichloride and biomolecules Inorganica Chimica Acta 2009 362 1303
26. Kapp T., Mller S., Gust R., Dinuclear alkylamine platinum(II) complexes of [1,2-bis(4-fluorophenyl) ethylenediamine]-platinum(II): influence of endocytosis and copper and organic cation transport systems on cellular uptake ChemMedChem 2006 1 5 560 564